Literature DB >> 16254208

Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction.

Anne-Louise Hemdahl1, Anders Gabrielsen, Chaoyong Zhu, Per Eriksson, Ulf Hedin, Jens Kastrup, Peter Thorén, Göran K Hansson.   

Abstract

OBJECTIVE: Neutrophil gelatinase-associated lipocalin (NGAL) modulates the activity of matrix metalloproteinase (MMP) 9, an important mediator of vascular remodeling and plaque instability in atherosclerosis. This study aimed to analyze the expression of NGAL in atherosclerotic plaques and myocardial infarction (MI). METHODS AND
RESULTS: Atherosclerotic apolipoprotein E (apoE)(-/-) x low-density lipoprotein receptor (LDLR)(-/-) and C57BL/6J control mice were exposed to brief hypoxic stress (10 minutes of 10% oxygen). Expression of the mouse NGAL homolog (24p3) and MMP-9 was analyzed 48 hours later by quantitative RT-PCR, immunohistochemistry, and zymography. Hypoxic stress increased NGAL/24p3 mRNA in the cardiac vasculature. NGAL/24p3 was also increased in atherosclerotic plaques of apolipoprotein E(-/-) x LDLR(-/-) mice compared with C57BL/6J mice. Mice developing MI exhibited the highest plaque mRNA expression of NGAL/24p3 and MMP-9. Zymography revealed strong proteolytic activity in areas rich in 24p3 and MMP-9 protein. Immunohistochemistry performed on human carotid endarterectomy specimens and control tissue from the internal mammary artery showed colocalization of MMP-9 and NGAL with macrophages in the atherosclerotic plaques.
CONCLUSIONS: NGAL/24p3 is increased in atherosclerotic plaques and MI. Colocalization with MMP-9 in areas with high-proteolytic activity suggests a role for NGAL/24p3 in modulating the MMP-9-mediated remodeling of plaques and infarcted hearts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254208     DOI: 10.1161/01.ATV.0000193567.88685.f4

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  108 in total

1.  Foetal hypoxia impacts methylome and transcriptome in developmental programming of heart disease.

Authors:  Lei Huang; Xin Chen; Chiranjib Dasgupta; Wanqiu Chen; Rui Song; Charles Wang; Lubo Zhang
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

2.  Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis.

Authors:  Subhankar Chakraborty; Sukhwinder Kaur; Venkata Muddana; Neil Sharma; Uwe A Wittel; Georgios I Papachristou; David Whitcomb; Randall E Brand; Surinder K Batra
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

3.  Cardiorenal syndrome type 4: a review.

Authors:  Anna Clementi; Grazia Maria Virzì; Ching Yan Goh; Dinna N Cruz; Antonio Granata; Girogio Vescovo; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2013-04       Impact factor: 2.041

Review 4.  Screening for chronic kidney disease in HIV-infected patients.

Authors:  Michelle M Estrella; Derek M Fine
Journal:  Adv Chronic Kidney Dis       Date:  2010-01       Impact factor: 3.620

5.  Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease.

Authors:  Mark M Mitsnefes; Thelma S Kathman; Jaya Mishra; Janis Kartal; Philip R Khoury; Thomas L Nickolas; Jonathan Barasch; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2006-10-27       Impact factor: 3.714

6.  Neutrophil gelatinase-associated lipocalin induces the expression of heme oxygenase-1 and superoxide dismutase 1, 2.

Authors:  Parisa Bahmani; Raheleh Halabian; Mehdi Rouhbakhsh; Amaneh Mohammadi Roushandeh; Nasser Masroori; Majid Ebrahimi; Ali Samadikuchaksaraei; Mohammad Ali Shokrgozar; Mehryar Habibi Roudkenar
Journal:  Cell Stress Chaperones       Date:  2009-11-11       Impact factor: 3.667

Review 7.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

8.  Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis.

Authors:  Michiko Suzuki; Kristina M Wiers; Marisa S Klein-Gitelman; Kathleen A Haines; Judyann Olson; Karen B Onel; Kathleen O'Neil; Murray H Passo; Nora G Singer; Lori Tucker; Jun Ying; Prasad Devarajan; Hermine I Brunner
Journal:  Pediatr Nephrol       Date:  2008-01-17       Impact factor: 3.714

Review 9.  Innate and adaptive immunity in atherosclerosis.

Authors:  René R S Packard; Andrew H Lichtman; Peter Libby
Journal:  Semin Immunopathol       Date:  2009-05-16       Impact factor: 9.623

10.  Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance.

Authors:  David R McIlroy; Gebhard Wagener; H Thomas Lee
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.